↓ Skip to main content

Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: From the Beginning to the Latest Developments

Overview of attention for article published in Frontiers in oncology, July 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (57th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: From the Beginning to the Latest Developments
Published in
Frontiers in oncology, July 2022
DOI 10.3389/fonc.2022.912699
Pubmed ID
Authors

Giandomenico Roviello, Martina Catalano, Raffaella Santi, Matteo Santoni, Ilaria Camilla Galli, Andrea Amorosi, Wojciech Polom, Ugo De Giorgi, Gabriella Nesi

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 2 10%
Student > Master 2 10%
Student > Bachelor 1 5%
Researcher 1 5%
Professor > Associate Professor 1 5%
Other 1 5%
Unknown 12 60%
Readers by discipline Count As %
Medicine and Dentistry 3 15%
Neuroscience 2 10%
Immunology and Microbiology 1 5%
Sports and Recreations 1 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Other 0 0%
Unknown 12 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 March 2024.
All research outputs
#15,218,027
of 26,314,361 outputs
Outputs from Frontiers in oncology
#4,068
of 22,971 outputs
Outputs of similar age
#182,546
of 439,149 outputs
Outputs of similar age from Frontiers in oncology
#272
of 1,770 outputs
Altmetric has tracked 26,314,361 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,971 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,149 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.
We're also able to compare this research output to 1,770 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.